The Clinical and Regulatory Affairs Team at Alnylam Pharmaceuticals is responsible for overseeing clinical development and ensuring that RNAi therapeutic products meet regulatory standards. This team coordinates clinical trials, manages regulatory submissions, and ensures compliance with global standards to facilitate the market introduction of RNAi medicines. They work cross-functionally to gather and analyze data, maintain quality assurance, and secure approvals from health authorities worldwide.
Abby O'Keefe
Senior Director, Head Of US Ta...
Akihiro Sawa
Senior Manager, Regulatory Aff...
Alison Allen
Director, Global Pharmacovigil...
Amy Chan-Daniels
Director, Clinical Science
Andrew McLaughlin
Global Business Intelligence L...
Anton Pavlov
Sr. Manager, Customer Data & M...
Ariel Friedman
Senior Specialist, External Op...
Billy S.
Global Partner & Emerging Mark...
Bob Tse
Lead, US Integrated Insights
Catalina Driscoll
Global Commercial Development ...
Catheryne Lin
Director, US Business Intellig...
Daniel Stiglitz
Manager Biostatistics
Elisa Prior
Senior Director Clinical Opera...
Fabrizio Cacace
Manager, Global Pharmacovigila...
Janna Curtis
Vice President, Head Of Medica...
Joseph Barry
Associate Director, Data Scien...
Kara Sherwood
Senior Manager, Training Opera...
Maged Darwish
Vice President, Global Regulat...
Mariya Sotirova
Director, Global Regulatory Af...
Melissa Strange Mba-...
Associate Director Standards, ...
Nadja Rozovsky
Associate Director, Program Ma...
Neeraja Krishnaswamy...
Lead Of Global Analytics & Dat...
Nitender Goyal
Director Clinical Research
Paul Miller
Vice President, Regulatory Tec...
Rita V. Amirana
Head Of CNS Portfolio, Clinica...
Ryan Gryder
Senior Manager, Biostatistics
Stephen Listzwan
Vice President, Global Strateg...
Thierry Yves Dieterl...
Senior Director - Head Of Cent...
Xingyu Li
Senior Manager, Biostatistics
View all